ONMD — Onemednet Income Statement
0.000.00%
- $11.54m
- $14.29m
- $0.64m
Annual income statement for Onemednet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.824 | 1.09 | 1.15 | 1.02 | 0.643 |
Cost of Revenue | |||||
Gross Profit | 0.212 | -0.113 | -0.361 | -0.128 | -0.281 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.76 | 3.8 | 7.27 | 19.9 | 10.2 |
Operating Profit | -2.93 | -2.71 | -6.12 | -18.9 | -9.61 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.82 | -2.94 | -6.57 | -23.2 | -10.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.82 | -2.94 | -6.57 | -23.2 | -10.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.82 | -2.94 | -6.57 | -23.2 | -10.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.82 | -2.94 | -6.57 | -23.2 | -10.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.083 | -0.086 | -0.193 | -0.545 | -0.361 |